Clinical trials explored the therapeutic value of monoclonal anti-TNF-α treatments, with some documenting significant relief of pain in rheumatoid arthritis, ankylosing spondylitis, and chronic radiculopathy. This evidence concerns the gene TNF and ankylosing spondylitis.